Skip to content

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma? - Can I predict the effectiveness of medication therapy and risk of recurrence with preoperative examinations in GH-producing pituitary adenoma?

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035076
Enrollment
70
Registered
2018-12-01
Start date
2018-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acromegaly

Interventions

None listed

Sponsors

Graduate school of medicine and faculty of medicine Kyoto university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with acromegaly based on `guideline of diagnosis and treatment with acromegaly` published by japan endocrine society.

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

MeasureTime frame
Exploring pre-operative marker which can predict post-operative prognosis

Secondary

MeasureTime frame
1. relationship between diagnostic imaging study and hormonal findings 2. exploring effective factor of medication therapy

Countries

Japan

Contacts

Public ContactSachiko Kawashima

Kyoto university hospital Department of diabetes, endocrinology and nutrition

kyotorinsho@gmail.com075-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026